STEM CELL THERAPY
The Asiri Group signed an agreement with Stempeutics Research Pvt Ltd. (http://www.stempeutics.com) and the Manipal Institute of Regenerative Medicine (MIRM) - Manipal Groups' Stem Cell Research, Development, Clinical Trials, and Education arms to commence stem cell research, development, clinical trials and education in Sri Lanka. MIRM is the first Institute for Regenerative Medicine5t4t in India. To operationalize this agreement Asiri's state of the art genetic laboratory will be developed into Asiri Centre for Genomic and Regenerative Medicine, commencing 1 August 2008. With the signing of this agreement Asiri will be able to offer stem cell therapy for patient with incurable diseases such as Parkinson Disease, Spinal Cord Injuries, Critical Limb Ischaemia, Motor Neuron Disease, and Myocardial Infarction brining hope for patients with these conditions.
The picture below shows representatives from Asiri and Stempeutics at the signing ceremony on 24 July 2008 at Asiri Surgical Hospital.
From Left to Right; Dr. Vajira H. W. Dissanayake (Clinical Geneticist and co-ordinator of the project), Dr. Manjula Karunarathne (Chief Operating Officer, Asiri Group), Mr. Ashok Pathirage (Managing Director, Asiri Group), Mr. B.N, Manohar (President, Stempeutics) and Dr. Vijay Sharma (Dean, Manipal Institute of Regenerative Medicine).
Contact ACGRM if you are interested in stem cell therapy [firstname.lastname@example.org]